OXA1L mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect.
Thompson K, Mai N, Oláhová M, Scialó F, Formosa LE, Stroud DA, Garrett M, Lax NZ, Robertson FM, Jou C, Nascimento A, Ortez C, Jimenez-Mallebrera C, Hardy SA, He L, Brown GK, Marttinen P, McFarland R, Sanz A, Battersby BJ, Bonnen PE, Ryan MT, Chrzanowska-Lightowlers ZM, Lightowlers RN, Taylor RW.
Thompson K, et al. Among authors: jou c.
EMBO Mol Med. 2018 Nov;10(11):e9060. doi: 10.15252/emmm.201809060.
EMBO Mol Med. 2018.
PMID: 30201738
Free PMC article.